Caduet and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Caduet (amlodipine besylate; atorvastatin calcium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin C, and have Glaucoma.

The phase IV clinical study analyzes which people have Nosebleed when taking Caduet. It is created by eHealthMe based on reports of 4,989 people who have side effects when taking Caduet from the FDA, and is updated regularly.

What is Caduet?

Caduet has active ingredients of amlodipine besylate; atorvastatin calcium. It is often used in high blood pressure. eHealthMe is studying from 5,157 Caduet users. Check the latest studies of Caduet.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 13, 2026

4,989 people reported to have side effects when taking Caduet.
Among them, 43 people (0.86%) have Nosebleed.

Among these 43 people:

How long have people been on Caduet when they have Nosebleed? *

What is the gender of people who have Nosebleed when taking Caduet? *

female: 45.24 %
male: 54.76 %

What is the age of people who have Nosebleed when taking Caduet? *

What are other drugs people take besides Caduet? *

What are other side effects people have besides Nosebleed? *

Weakness: 14 people, 32.56%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 27.91%
Diarrhea: 10 people, 23.26%
Stress And Anxiety: 8 people, 18.60%
Cough: 8 people, 18.60%
Headache (pain in head): 7 people, 16.28%
Fatigue (feeling of tiredness): 7 people, 16.28%
Renal Disorder (kidney disease): 7 people, 16.28%
Peripheral Swelling: 7 people, 16.28%
Cardiac Valve Disease (heart valve disease): 7 people, 16.28%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 13.95%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 13.95%
Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 13.95%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 9.30%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 9.30%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.98%
Hypersensitivity: 2 people, 4.65%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 2 people, 4.65%
Sleep Disorder: 2 people, 4.65%
Asthma: 2 people, 4.65%

* Approximation only. Some reports may have incomplete information.

Do you take Caduet and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Caduet:

Caduet (5,157 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

How severe was Nosebleed and when was it recovered:

Nosebleed in Caduet

Expand to all the drugs that have ingredients of amlodipine besylate; atorvastatin calcium:

Nosebleed and drugs with ingredients of amlodipine besylate; atorvastatin calcium (47 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Caduet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,080 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,093 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; atorvastatin calcium (the active ingredients of Caduet) and Caduet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.